Moxifloxacin
Formulations: - Oral > Solid > tablet: 400 mg Oral > Solid > dispersible tablet: 100 mg Indications: - Tuberculosis - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
Vendor: Marketplace supplier
Product metadata will be available once the catalog entry is complete.
Formulations: - Oral > Solid > tablet: 400 mg Oral > Solid > dispersible tablet: 100 mg Indications: - Tuberculosis - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
Formulations: - Oral > Solid > tablet: 200 mg Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
Formulations: - Oral > Liquid: 5.52 g in sachet (equivalent to 4 g p-aminosalicylic acid) powder for oral solution Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
Formulations: - Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 400 mg; 500 mg Indications: - Tuberculosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection Indications: - Multi-drug resistant Mycobacterium tuberculosis - Neonatal meningitis - Peritonitis (severe) - Peritoneal abscess (severe) - Neutropenia (high-risk) Source: EML workbook import
Formulations: - Oral > Solid > dispersible tablet: 150 mg (scored) Oral > Solid > tablet: 600 mg - Parenteral > General injections > IV: 2 mg per mL in 300 mL bag Oral > Liquid: 100 mg per 5 mL powder for oral liquid Oral > Solid: 400 mg tablet; 600 mg tablet Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 600 mg Indications: - Multi-drug resistant Mycobacterium tuberculosis - Other specified bacterial diseases - Methicillin resistant Staphylococcus aureus - Vancomycin resistant Staphylococcus aureus - Vancomycin resistant Enterococcus Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.